Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions

 

View bio business grants awarded by year.
Patrick Walsh, MS
This proposal will expand Anatomic facilities through equipment purchases to establish an independent laboratory. This will create room for…
2021-2022
Artur Serebrenik, PhD
The primary goal of the proposed work is to produce preclinical data to support the use of BIO 300 in patients with triple negative breast cancer…
2021-2022
Timothy O'Brien, DVM, PhD
Our goal is to develop a therapeutic product that can arrest or reverse the progress of osteoarthritis of the knee, delay or obviate the need for…
2021-2022
Andrew Lewis, PhD
The goal of this project is develop a platform for engineering cells from non-autologous sources for cell therapy. We will use a transposon-based non…
2021-2022
Robert Kaiser, PhD, DABT
To procure and optimize processing of human hepatocytes for research and clinical purposes.
2021-2022
Ross Dunbar
Our goal is focused on developing the commercial pathway for two translational stem cell related projects in Minnesota, one creating Rapidly…
2021-2022
Maria Athanasiou, PhD
We are developing a one-time treatment for durable remission of HIV in the absence of antiretroviral treatment. This treatment is a regenerative…
2021-2022
Vanesa Alonso-Camino, PhD
The central goal of this proposal is to conduct a viral clearance validation study. To meet the growing demand of pathogen reduced hPL used in…
2021-2022
Timothy O'Brien, DVM, PhD
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021
Wesley Wierson, PhD
LEAH Labs is bringing regenerative immunotherapy to dogs. We use gene editing to enable the translation of cell therapies from successful…
2020-2021
Dave Roeser
We have seven specific milestones with the goal of making bone morphogenetic protein and fibronectin (used to promote bone repair) that is…
2020-2021
Timothy O'Brien, DVM, PhD
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021